REDUCTION IN HIGH BLOOD TUMOR NECROSIS FACTOR-α LEVELS AFTER MANIPULATIVE THERAPY IN 2 CERVICOGENIC HEADACHE PATIENTS

被引:8
作者
Ormos, Gabor [1 ]
Mehrishi, J. N. [2 ,3 ,4 ,5 ]
Bakacs, Tibor [6 ]
机构
[1] HNIRP, Outpatient Clin, Dept Rehabil, H-1023 Budapest, Hungary
[2] Univ Cambridge, Cambridge Blood Initiat, Cambridge, England
[3] Univ Cambridge, Stem Cells Initiat, Cambridge, England
[4] Univ Cambridge, Spermatozoa Initiat, Cambridge, England
[5] Univ Cambridge, Opioid Res Initiat, Cambridge, England
[6] Hungarian Acad Sci, Dept Probabil, Alfred Renyi Inst Math, Budapest, Hungary
关键词
Cervicogenic Headache; Tumor Necrosis Factor-alpha; Musculoskeletal Manipulations; Whiplash Injuries; RHEUMATOID-ARTHRITIS; PATHOPHYSIOLOGY; ANTIBODIES;
D O I
10.1016/j.jmpt.2009.08.006
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: This case report discusses the treatment of 2 patients with cervicogenic headache (CHA) attending the Outpatient Clinic of the Hungarian National Institute for Rheumatology and Physiotherapy (Budapest, Hungary) and reviews the pathophysiology, therapeutic strategy, and problems associated with the treatment of CHA. Clinical Features: Patient 1 was a 27-year-old female who sustained a whiplash injury. A sharp, shooting headache developed, readily induced, and aggravated by just bending the neck backward or by turning her head. Magnetic resonance imaging revealed a disk protrusion at C4-C5 pressing the anterior cerebrospinal space. Patient 2 was a 62-year-old female who sustained a whiplash injury; her cervical movements became restricted, which precipitated headaches. Magnetic resonance imaging revealed a paramedian disk hernia between the C4 and C5 vertebrae that intruded into the right ventral cerebrospinal space. Intervention and Outcome: After 4 weeks of manipulative therapy for patient 1, both active and passive range of motion returned to normal, and the high tumor necrosis factor-alpha (TNF-alpha) level (63 pg/mL) was substantially reduced (28 pg/mL). Patient 2 was started on manipulative therapy twice a week for 4 weeks; after 2 months, the patient became symptom-free, and high TNF-alpha level (72 pg/mL) was reduced greatly (35 pg/mL). Conclusion: Two patients with whiplash injury and disk herniation developed CHA associated with very high TNF-alpha levels. After manipulative therapy, these patients became symptom-free, and their TNF-alpha levels decreased substantially. (J Manipulative Physiol Ther 2009;32:586-591)
引用
收藏
页码:586 / 591
页数:6
相关论文
共 50 条
  • [21] Chimeric anti-tumor necrosis factor-α monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
    Kavanaugh, A
    St Clair, EW
    McCune, WJ
    Braakman, T
    Lipsky, P
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (04) : 841 - 850
  • [22] Anti-tumor necrosis factor-α therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis
    Uguz, Faruk
    Akman, Cemal
    Kucuksarac, Seher
    Tufekci, Osman
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (01) : 50 - 55
  • [23] Clinical and Histologic Findings in Patients With Uveal Melanomas After Taking Tumor Necrosis Factor-α Inhibitors
    Damento, Gena
    Kavoussi, Shaheen C.
    Materin, Miguel A.
    Salomao, Diva R.
    Quiram, Polly A.
    Balasubramaniam, Soranya
    Pulido, Jose S.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (11) : 1481 - 1486
  • [24] Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes
    Engebretson, S.
    Chertog, R.
    Nichols, A.
    Hey-Hadavi, J.
    Celenti, R.
    Grbic, J.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2007, 34 (01) : 18 - 24
  • [25] Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients
    Vaccarino, Loredana
    Vitale, Silvana
    Caruso, Marco
    Palmeri, Marisa
    Scola, Letizia
    Bova, Manuela
    Caruso, Calogero
    Massenti, Maria Fatima
    Vitale, Francesco
    Novo, Salvatore
    Lio, Domenico
    Forte, Giusi Irma
    CYTOKINE, 2013, 61 (01) : 218 - 222
  • [26] Genetic variants of tumor necrosis factor-α and its levels: A correlation with dyslipidemia and type 2 diabetes susceptibility
    Patel, Roma
    Palit, Sayantani Pramanik
    Rathwa, Nirali
    Ramachandran, A. V.
    Begum, Rasheedunnisa
    CLINICAL NUTRITION, 2019, 38 (03) : 1414 - 1422
  • [27] Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
    Maeki-Petaejae, Kaisa M.
    Elkhawad, Maysoon
    Cheriyan, Joseph
    Joshi, Francis R.
    Oestoer, Andrew J. K.
    Hall, Frances C.
    Rudd, James H. F.
    Wilkinson, Ian B.
    CIRCULATION, 2012, 126 (21) : 2473 - 2480
  • [28] Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
    Yoo, In Kyung
    Choung, Rok Seon
    Hyun, Jong Jin
    Kim, Seung Young
    Jung, Sung Woo
    Koo, Ja Seol
    Lee, Sang Woo
    Choi, Jai Hyun
    Kim, Ho
    Lee, Hong Sik
    Keum, Bora
    Kim, Eun Sun
    Jeen, Yoon Tae
    YONSEI MEDICAL JOURNAL, 2014, 55 (02) : 442 - 448
  • [29] Clearance of [125I] tumor necrosis factor-α from the brain into the blood after intracerebroventricular injection in rats
    Chen, GJ
    Reichlin, S
    NEUROIMMUNOMODULATION, 1998, 5 (05) : 261 - 269
  • [30] Plasma tumor necrosis factor-α, its soluble receptors and interleukin-1β levels in critically burned patients
    Zhang, B
    Huang, YH
    Chen, Y
    Yang, Y
    Hao, ZL
    Xie, SL
    BURNS, 1998, 24 (07) : 599 - 603